The safety of Cervarix? – Authors' reply

HPV-015 study group

Research output: Contribution to journalLetter

Original languageEnglish
Pages (from-to)20-21
Number of pages2
JournalLancet Infectious Diseases
Volume17
Issue number1
DOIs
Publication statusPublished - Jan 2017

Cite this

The safety of Cervarix? – Authors' reply. / HPV-015 study group.

In: Lancet Infectious Diseases, Vol. 17, No. 1, 01.2017, p. 20-21.

Research output: Contribution to journalLetter

HPV-015 study group. / The safety of Cervarix? – Authors' reply. In: Lancet Infectious Diseases. 2017 ; Vol. 17, No. 1. pp. 20-21.
@article{ee0b221e74934d8180336bb050ccba7a,
title = "The safety of Cervarix? – Authors' reply",
author = "Wheeler, {Cosette M} and Frank Struyf and {HPV-015 study group} and Cruickshank, {Margaret Eleanor}",
year = "2017",
month = "1",
doi = "10.1016/S1473-3099(16)30540-0",
language = "English",
volume = "17",
pages = "20--21",
journal = "Lancet Infectious Diseases",
issn = "1473-3099",
publisher = "ELSEVIER APPL SCI PUBL LTD",
number = "1",

}

TY - JOUR

T1 - The safety of Cervarix? – Authors' reply

AU - Wheeler, Cosette M

AU - Struyf, Frank

AU - HPV-015 study group

AU - Cruickshank, Margaret Eleanor

PY - 2017/1

Y1 - 2017/1

U2 - 10.1016/S1473-3099(16)30540-0

DO - 10.1016/S1473-3099(16)30540-0

M3 - Letter

VL - 17

SP - 20

EP - 21

JO - Lancet Infectious Diseases

JF - Lancet Infectious Diseases

SN - 1473-3099

IS - 1

ER -